» Articles » PMID: 37757589

Viscosity Prediction of High-Concentration Antibody Solutions with Atomistic Simulations

Overview
Date 2023 Sep 27
PMID 37757589
Authors
Affiliations
Soon will be listed here.
Abstract

The computational prediction of the viscosity of dense protein solutions is highly desirable, for example, in the early development phase of high-concentration biopharmaceutical formulations where the material needed for experimental determination is typically limited. Here, we use large-scale atomistic molecular dynamics (MD) simulations with explicit solvation to predict the dynamic viscosities of solutions of a monoclonal IgG1 antibody (mAb) from the pressure fluctuations using a Green-Kubo approach. The viscosities at simulated mAb concentrations of 200 and 250 mg/mL are compared to the experimental values, which we measured with rotational rheometry. The computational viscosity of 24 mPa·s at the mAb concentration of 250 mg/mL matches the experimental value of 23 mPa·s obtained at a concentration of 213 mg/mL, indicating slightly different effective concentrations (or activities) in the MD simulations and in the experiments. This difference is assigned to a slight underestimation of the effective mAb-mAb interactions in the simulations, leading to a too loose dynamic mAb network that governs the viscosity. Taken together, this study demonstrates the feasibility of all-atom MD simulations for predicting the properties of dense mAb solutions and provides detailed microscopic insights into the underlying molecular interactions. At the same time, it also shows that there is room for further improvements and highlights challenges, such as the massive sampling required for computing collective properties of dense biomolecular solutions in the high-viscosity regime with reasonable statistical precision.

Citing Articles

Reconciling predicted and measured viscosity parameters in high concentration therapeutic antibody solutions.

Armstrong G, Roche A, Lewis W, Rattray Z MAbs. 2024; 16(1):2438172.

PMID: 39663541 PMC: 11790245. DOI: 10.1080/19420862.2024.2438172.


Residue-resolved insights into the stabilization of therapeutic proteins by excipients: A case study of two monoclonal antibodies with arginine and glutamate.

Prass T, Garidel P, Schafer L, Blech M MAbs. 2024; 16(1):2427771.

PMID: 39540607 PMC: 11572152. DOI: 10.1080/19420862.2024.2427771.


Heterogeneous Slowdown of Dynamics in the Condensate of an Intrinsically Disordered Protein.

Mukherjee S, Schafer L J Phys Chem Lett. 2024; 15(45):11244-11251.

PMID: 39486437 PMC: 11571228. DOI: 10.1021/acs.jpclett.4c02142.


A First Insight into the Developability of an Immunoglobulin G3: A Combined Computational and Experimental Approach.

Armstrong G, Lewis A, Shah V, Taylor P, Jamieson C, Burley G ACS Pharmacol Transl Sci. 2024; 7(8):2439-2451.

PMID: 39144567 PMC: 11320737. DOI: 10.1021/acsptsci.4c00271.


Stability of Protein Pharmaceuticals: Recent Advances.

Manning M, Holcomb R, Payne R, Stillahn J, Connolly B, Katayama D Pharm Res. 2024; 41(7):1301-1367.

PMID: 38937372 DOI: 10.1007/s11095-024-03726-x.


References
1.
Robustelli P, Piana S, Shaw D . Developing a molecular dynamics force field for both folded and disordered protein states. Proc Natl Acad Sci U S A. 2018; 115(21):E4758-E4766. PMC: 6003505. DOI: 10.1073/pnas.1800690115. View

2.
Saporiti S, Parravicini C, Pergola C, Guerrini U, Rossi M, Centola F . IgG1 conformational behavior: elucidation of the N-glycosylation role via molecular dynamics. Biophys J. 2021; 120(23):5355-5370. PMC: 8715174. DOI: 10.1016/j.bpj.2021.10.026. View

3.
Gopal S, Wingbermuhle S, Schnatwinkel J, Juber S, Herrmann C, Schafer L . Conformational Preferences of an Intrinsically Disordered Protein Domain: A Case Study for Modern Force Fields. J Phys Chem B. 2020; 125(1):24-35. DOI: 10.1021/acs.jpcb.0c08702. View

4.
Bahrenburg S, Karow A, Garidel P . Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: from protein buffer capacity prediction to bioprocess applications. Biotechnol J. 2015; 10(4):610-22. DOI: 10.1002/biot.201400531. View

5.
Chari R, Jerath K, Badkar A, Kalonia D . Long- and short-range electrostatic interactions affect the rheology of highly concentrated antibody solutions. Pharm Res. 2009; 26(12):2607-18. DOI: 10.1007/s11095-009-9975-2. View